Drug Manufacturers Specialty Generic Industry Analysis

84 companies analyzed • Returns from -249.4% to +333.0% • Data through Mar 19, 2026

Company List (84 Results)

View:

Sort:

Industry Performance

(84/84 companies)

2025-03-21 → 2026-03-19

Weighted Avg

+6.2%

Median

-0.5%

Best

+333.0%

Worst

-249.4%

Returns Distribution

Top 5

1. UPC+333.0%2. ASRT+294.4%3. FLGC+261.8%4. TLRY+232.7%5. BIOA+154.5%

Bottom 5

1. BGM-249.4%2. ALVOW-217.3%3. ZYBT-149.9%4. INM-122.1%5. RDHL-121.4%

1–20 of 84

Page 1 of 5

Methodology

The Weighted Average return (+6.2%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.

81 companies with market cap data included: UPC, ASRT, FLGC, TLRY, BIOA, EVOK, IXHL, INDV, YCBD, AVDL and 71 more...

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer

Drug Manufacturers Specialty Generic Industry Analysis

Company List (84 Results)

Industry Performance

UPC

ASRT

FLGC

TLRY

BIOA

EVOK

IXHL

INDV

YCBD

AVDL

TXMD

PAHC

ELAN

CPHI

IRWD

SHPH

AYTU

KNSA

TEVA

UTHR